Clinical trial
Efficacy of Zydena (Udenafil) on Cognitive Function of Alzheimer's Disease Patients: A Randomized, Double Blind, Placebo-controlled Multicenter Study
NCT01940952 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Zydena (Udenafil) on Cognitive Function of Alzheimer's Disease Patients: A Randomized, Double Blind, Placebo-controlled Multicenter Study
- Lead sponsor
- Samsung Medical Center
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- September 30, 2013
- Completion date
- Not reported
- Enrollment
- 210 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease